Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experience

Autor: Michael Crist, Gopa Iyer, Miles Hsu, William C. Huang, Arjun V. Balar

Publikováno v: Therapeutic Advances in Urology, Vol 11 (2019)

The treatment of advanced urothelial carcinoma (UC) has dramatically changed with the advent of immune checkpoint inhibitors that disrupt the T-cell inhibitory interaction between the programmed cell death (PD)-1 receptor and its ligand (PD-L1). Pemb

Externí odkaz: https://doaj.org/article/a91c02a633c045028832506684d6fbb4

Experiences of African Americans Living With Sickle Cell Disease.

Autor: Wickersham KE; University of South Carolina, Columbia, USA., Dawson RM; University of South Carolina, Columbia, USA., Becker KP; University of South Carolina, Columbia, USA., Everhart KC; University of South Carolina, Columbia, USA., Miles HS; University of South Carolina, Columbia, USA., Schultz BE; University of South Carolina, Columbia, USA., Tucker CM; University of South Carolina, Columbia, USA., Wright PJ; University of South Carolina, Columbia, USA., Jenerette CM; University of South Carolina, Columbia, USA.

Publikováno v: Journal of transcultural nursing : official journal of the Transcultural Nursing Society [J Transcult Nurs] 2022 May; Vol. 33 (3), pp. 334-345. Date of Electronic Publication: 2022 Jan 31.

The conjunctival flap and the cataract wound.

Autor: Wilson FM, Miles HS

Publikováno v: Transactions of the American Ophthalmological Society [Trans Am Ophthalmol Soc] 1902; Vol. 9, pp. 503-11.